Device Therapy Recommendations In Recent Heart Failure Guidelines: A Closer Look

Device Therapy Recommendations In Recent Heart Failure Guidelines: A Closer Look

Bibliographic Details
Main Authors:	Oben Baysan, İlke Zehra Yıldız
Format:	Article
Language:	English
Published:	Center for Scientific Research and Development of Education. 2022-06-01
Series:	Heart Vessels and Transplantation
Subjects:	heart failure guidelines device therapy
Online Access:	http://hvt-journal.com/articles/art318

Similar Items

Editorial comment on “A practical guideline for performing a comprehensive transthoracic echocardiogram in the congenital heart disease patient” 2022 British Society of Echocardiography
by: Oben Baysan, et al.
Published: (2023-02-01)

Key messages to comprehend: 2023 Focused Update of the 2021 European Society of Cardiology Guidelines for the diagnosis and treatment of acute and chronic heart failure
by: Zehra Ilke Akyildiz, et al.
Published: (2023-12-01)

Heart failure guidelines implementation: Lifting barriers using registries and networks
by: Kalliopi Keramida, et al.
Published: (2020-07-01)

The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention
by: Arielle Abovich, et al.
Published: (2023-09-01)

Adherence to guideline-directed medical and device Therapy in outpAtients with heart failure with reduced ejection fraction: The ATA study
by: Umut Kocabaş, et al.
Published: (2020-07-01)

2023 Indonesian Guidelines for Heart Failure Treatment: Working Group on Heart Failure and Cardiometabolic Diseases, Indonesian Heart Association
by: Dian Yaniarti Hasanah, MD, et al.
Published: (2025-01-01)

Interpretation on Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024
by: TIAN Zhuang, et al.
Published: (2024-06-01)

European and American guidelines for the management of patients with heart failure - different recommendations based on the same research results?
by: Adam Stanczyk
Published: (2022-06-01)

Adherence to the European Society of Cardiology (ESC) guidelines for chronic heart failure - A national survey of the cardiologists in Pakistan
by: Shoukat Sana, et al.
Published: (2011-11-01)

Polypharmacy and Guideline-Directed Medical Therapy Initiation Among Adults Hospitalized With Heart Failure
by: Chukwuma Onyebeke, MD, et al.
Published: (2024-09-01)

Salt substitute recommendations for heart failure patients may influence guideline‐directed medical therapies titration
by: Jean‐Michel Tartière, et al.
Published: (2024-08-01)

Adaptation of interdisciplinary clinical practice guidelines to palliative care for patients with heart failure in iran: application of adapte method
by: Imane Bagheri, et al.
Published: (2023-01-01)

Guideline-directed device therapies in heart failure: A clinical practice-based analysis using electronic health record data
by: Anne B. Curtis, et al.
Published: (2022-04-01)

Guideline implementation, drug sequencing, and quality of care in heart failure: design and rationale of TITRATE‐HF
by: Pascal R. D. Clephas, et al.
Published: (2024-02-01)

The use of four-pillar regimen for heart failure management: results from the Jordanian Heart Failure Registry (JoHFR)
by: Mahmoud Izraiq, et al.
Published: (2024-11-01)

The heart failure epidemic: a UK perspective
by: Martin R Cowie
Published: (2017-03-01)

Acute decompensated heart failure. What has changed in the clinical guidelines in 2021?
by: Igor V. Zhirov, et al.
Published: (2022-01-01)

Summary of updates to the 2021 European Society of Cardiology Guidelines for the diagnosis and treatment of acute and chronic heart failure
by: V. N. Larina, et al.
Published: (2022-03-01)

Recent Advances in the Wearable Devices for Monitoring and Management of Heart Failure
by: Victor Adeyi Odeh, et al.
Published: (2024-10-01)

European Society of Cardiology guidelines and 1 year outcomes of acute heart failure treatment in Central Asia and Europe
by: Tamila Abdurashidova, et al.
Published: (2024-02-01)

Summary and Comparison of the 2022 ACC/AHA/HFSA and 2021 ESC Heart Failure Guidelines
by: Sarah Badger, et al.
Published: (2023-08-01)

Multimorbidity, guideline‐directed medical therapies, and associated outcomes among hospitalized heart failure patients
by: Shinsuke Takeuchi, et al.
Published: (2022-08-01)

Classification of heart failure: focus on prevention
by: E. V. Shlyakhto
Published: (2023-02-01)

Retrospective Evaluation and Analysis of Pharmacoequity with Guideline-directed Medical Therapy in Heart Failure with Reduced Ejection Fraction (REAP-HF)
by: Morgan Streett, et al.
Published: (2025-02-01)

Heart failure : device management /
by: Feldman, Arthur M. (Arthur Michael), 1949-
Published: (2010)

ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison
by: Amir Hossein Behnoush, et al.
Published: (2023-06-01)

Use of Guideline-Recommended Heart Failure Drugs in High-, Middle-, and Low-Income Countries: A Systematic Review and Meta-Analysis
by: Gautam Satheesh, et al.
Published: (2024-09-01)

Interpretation of the Essential Updates in 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
by: Yifang GUO
Published: (2022-06-01)

Device-based therapy for decompensated heart failure: An updated review of devices in development based on the DRI2P2S classification
by: Cristiano de Oliveira Cardoso, et al.
Published: (2022-09-01)

Review and adaptation of European Federation of Internal Medicine clinical guidelines on acute heart failure
by: V. N. Larina, et al.
Published: (2024-08-01)

A systematic review on clinical guidelines of home health care in heart failure patients
by: Leila Hashemlu, et al.
Published: (2023-04-01)

Beyond Medical Therapy—An Update on Heart Failure Devices
by: Luigi Falco, et al.
Published: (2024-06-01)

Current and Future Drug and Device Therapies for Pediatric Heart Failure Patients: Potential Lessons from Adult Trials
by: Bibhuti B. Das, et al.
Published: (2021-04-01)

Guideline‐Directed Medical Therapy After Hospitalization for Acute Heart Failure: Insights From the CONNECT‐HF
by: Satoshi Shoji, et al.
Published: (2024-12-01)

Eligibility for vericiguat in a real‐world, contemporary heart failure population
by: Giuseppe Vergaro, et al.
Published: (2024-12-01)

Clinical profile and 90 day outcomes of 10 851 heart failure patients across India: National Heart Failure Registry
by: Sivadasanpillai Harikrishnan, et al.
Published: (2022-12-01)

Practical Recommendations for the Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Heart Failure: Insights from Indian Cardiologists
by: Jamshed Dalal, et al.
Published: (2023-06-01)

Optimization of GDMT for patients with heart failure and reduced ejection fraction: can physiological and biological barriers explain the gaps in adherence to heart failure guidelines?
by: Marilyne Jarjour, et al.
Published: (2023-11-01)

Editorial: Case reports in heart failure and transplantation: 2022
by: Matteo Cameli, et al.
Published: (2023-09-01)

Real‐world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED–HEART study
by: Umut Kocabas, et al.
Published: (2025-02-01)